The path to a better tuberculosis vaccine runs through Missoula, Montana based Inimmune

A team of University of Montana researchers is playing a key role in the development of a more effective vaccine against an infectious disease that has killed more people than any other.
Jay Evans, the director of the University of Montana center and the chief scientific and strategy officer and a co-founder of Inimmune, a privately held biotechnology company in Missoula, said his team has been working on a TB vaccine for 15 years. The private-public partnership is developing vaccines and trying to improve existing vaccines, and he said it’s still five years off before the TB vaccine might be distributed widely.

Sorry, we couldn't find any posts. Please try a different search.

Leave a Comment

You must be logged in to post a comment.